CJC-1295 + Ipamorelin

CJC-1295 (no DAC) and Ipamorelin are commonly paired in research to study growth hormone (GH) pulsatility and secretagogue pathway signaling.

This combination is investigated in controlled settings for GH axis dynamics and downstream biomarker responses relevant to endocrine research.

For research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease.

What's Included:

• 5mg CJC-1295 (no DAC) + 5mg Ipamorelin

• Single-use research vial

• Lab-tested for purity and identity

• Certificate of Analysis included

Research Applications:

• Growth hormone (GH) secretion research

• GHRH and GHS receptor signaling studies

• GH-axis pulsatility investigations

• Synergistic GH-release pathway research

• Endocrine-function model studies

FAQ:

• Q: Why combine them? A: They work synergistically—CJC-1295 stimulates GHRH receptors; Ipamorelin stimulates GHS receptors.

• Q: Difference with/without DAC? A: DAC extends half-life. This is without DAC, suitable for pulsatile GH research.